Levodonna (Levonorgestrel)

Levonorgestrel binds to progesterone receptors in the hypothalamus and pituitary, suppressing the luteinizing hormone surge needed for ovulation. It also thickens cervical mucus and modifies the endometrial lining, reducing the likelihood of fertilization and implantation.

The specific dose and regimen of Levodonna are determined by the prescribing healthcare professional based on the indication, timing of administration, and patient factors. Patients should follow the prescriber’s instructions and the product labeling.

Levodonna is intended to prevent pregnancy and is not recommended for use during an established pregnancy. Its safety during breastfeeding has not been fully established; women should consult their healthcare provider before using it while nursing.

To place an order, submit an enquiry on the Levodonna product page at gnhindia.com, providing the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then responds with pricing, availability, shipping details, and any necessary import documentation.

Levodonna’s active ingredient, levonorgestrel, is a widely used progestin in emergency contraception, offering efficacy when taken within 72 hours of unprotected intercourse. Compared with ulipristal acetate, another option, levonorgestrel is generally less effective the longer the delay but is available over‑the‑counter in many regions.

Levodonna should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Levodonna is taken orally, usually as a single tablet or as directed by a healthcare professional. The tablet should be swallowed with water and taken as soon as possible after unprotected sexual activity for optimal effectiveness.

Although rare, serious adverse events can include thromboembolic disorders, severe allergic reactions such as anaphylaxis, and liver dysfunction. Patients experiencing symptoms like unexplained swelling, severe abdominal pain, rash, or breathing difficulties should seek immediate medical attention.

Levodonna is contraindicated in women who are pregnant, have a known hypersensitivity to levonorgestrel or any excipients, have active or a history of thromboembolic disease, severe liver disease, or undiagnosed abnormal vaginal bleeding. Consultation with a healthcare provider is essential before use.